glp-1 by mail Antagonists Increase Plan Drug Spend - What's Next GLP-1 Advanced Metabolic Extra Strength

The OFA argued that the FDAs removal of tirzepatide, the active ingredient in these drugs, from its shortage list would limit access to essential treatments and increase drug prices

Fear of movement is one of the most underappreciated drivers of persistent pain in hypermobility, and addressing it doesnt carry the risks of systemic medication

Altmed gives patients a local place to ask questions when side effects, insurance delays, prescription availability, or health changes come up

In a mouse model relevant to myalgic encephalomyelitis/chronic fatigue syndrome rather than FM, combined lipopolysaccharide administration and swim stress activated the diencephalic NLRP3 inflammasome, leading to caspase-1-mediated IL-1 maturation and fatigue-like motor deficits, while lactate and MDA levels remained unchanged